• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Geisinger Launches Virtual Chronic Disease Monitoring System Powered by Noteworth

by Jasmine Pennic 05/25/2021 Leave a Comment

What You Should Know:

– Geisinger today announced the launch of ConnectedCare365, an innovative care delivery model for patients with chronic diseases like diabetes, heart failure and hypertension available on Google Play and App Store. Powered by Noteworth, a digital health startup dedicated to rethinking healthcare delivery, this first-of-its-kind virtual care delivery platform uses remote patient monitoring, artificial intelligence and powerful data analysis tools to improve patient outcomes.

– This is especially timely given how the COVID-19 pandemic propelled patients and physicians to quickly adopt telehealth services including virtual visits, which according to one report, could potentially account for $250 billion, or about 20%, of what Medicare, Medicaid and commercial insurers spend on outpatient, office and home health visits.

– Throughout the partnership, Noteworth will provide technical and consultative support to drive Geisinger’s goals of improving health outcomes, increasing patient engagement, improving access to care and lowering costs.

ConnectedCare365 Overview

ConnectedCare365, which is powered by Noteworth’s technology, will work to address key clinical initiatives for: diabetes, heart failure, history of stroke risk and post-stroke care, chronic obstructive pulmonary disease (COPD), case management, behavioral health, COVID-19, and substance use disorder. Geisinger care teams will also use the platform to transition patient care after discharge from the hospital. It is unique because this collaboration opens the door to a fully-integrated delivery model not seen at any other healthcare organization.

In addition, this will also be beneficial in helping patients who are in more rural areas in the PA area who may not have quick access to Geisinger healthcare facilities.

“This is a fundamentally different approach to chronic disease management,” said Karen Murphy, RN, Ph.D., chief innovation officer and founding director of Geisinger’s Steele Institute for Health Innovation. “Using predictive analytics, as well as real-time analysis of clinical and patient-generated data, ConnectedCare365 will help our patients achieve their health goals and better manage chronic conditions. Our partnership with Noteworth strengthens our ongoing commitment to making better health easier by developing digital solutions to provide better care to our patients and ultimately drive down healthcare costs.”

Tagged With: Chronic Disease Monitoring, Noteworth

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Popular

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Northwell Health Extends Contract with Allscripts Sunrise Platform Through 2027

Northwell to Deploy Epic Enterprise EHR Platform Across System

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Pfizer Acquires Seagen for $43B to Tackle Cancer

Pfizer Acquires Seagen for $43B to Tackle Cancer

5 Key Trends Driving Purchasing Decisions in Healthcare IT

5 Key Trends Driving Purchasing Decisions in Healthcare IT

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Dr. Arti Masturzo

Q/A: Dr. Masturzo Talks Addressing Food Insecurity with Patients

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Q/A: Oatmeal Health Co-Founder Talks AI-Enabled Cancer Screening for the Underserved

Q/A: Oatmeal Health Co-Founder Talks AI-Enabled Cancer Screening for the Underserved

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |